試す金 - 無料

Bio Spectrum - BioSpectrum India Jan 2025

Magzter GOLDで無制限に

読む Bio Spectrum 9,500以上の雑誌や新聞を1回の定期購読で購読できます

カタログを見る

1ヶ月

$14.99

1年 $149.99

$149.99

$12/month

(OR)

Bio Spectrumのみを購読する

贈り物 Bio Spectrum

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

Indian Pharma Hits R&D Salvo Pharma companies are constantly on the quest to discover the next big game-changer drug or therapeutic by leveraging the latest, cutting-edge innovation. While it is notable that biopharma companies eased up on their research and development (R&D) spending in FY 2022-23 after the world was hit by COVID-19- induced economic slowdown, the budget for R&D has witnessed a steady increase. Departing a bit from their traditional drug portfolios, companies are increasingly focusing on R&D in next generation therapies to drive innovation, particularly in complex generics, biosimilars, cell and gene therapies and novel drug delivery systems.

CDSCO approves robotic system for telesurgery by SS Innovations

The developer of the country's first indigenous surgical robotic technology, SS Innovations, the visionary force behind Madein-India SSI Mantra Surgical Robotic System, has achieved a historic feat in Indian medical science by becoming the first and only company in India to receive Central Drugs Standard Control Organisation (CDSCO)'s regulatory approval for Telesurgery and Teleproctoring, signifying a monumental leap in surgical robotics.

1 mins

Health Ministry signs MoU with Banaras Hindu University and Ministry of Education to support Institute of Medical Sciences

Union Health Ministry has entered into a tripartite Memorandum of Understanding (MoU) with Banaras Hindu University (BHU) and Ministry of Education to provide enhanced funding and technical support to Institute of Medical Sciences (IMS), BHU.

1 mins

Piramal Alternatives Fund invests Rs 185 Cr in 3Gen Consulting

Piramal Alternatives Fund has entered into definitive agreements to invest upto Rs 185 crore via convertible instruments in 3Gen Consulting, a leading healthcare consulting and revenue cycle solutions provider with presence in India and across USA.

1 mins

Jagat Pharma endeavours for Rs 250+ Cr revenue by FY 2027

Jagat Pharma, a trusted name in Ayurvedic wellness, is poised for remarkable growth as it targets revenue exceeding Rs 250 crore by the financial year 2027.

1 mins

Aster DM Healthcare and Quality Care India ink definitive agreements for merger

Aster DM Healthcare, one of India's largest and fastest growing integrated healthcare service providers, and Quality Care India Limited (QCIL), backed by Blackstone and TPG, one of the largest privately held hospital chains in India with + a focus on emerging cities, have signed definitive agreements for a merger.

1 mins

$3B annual investment opportunity in climate-health adaptation for India

Quadria Capital, in association with HealthQuad and PwC India, has released a critical new report titled 'Financing the ClimateHealth Frontier: Emerging Opportunities.'

1 mins

PanGIA Biotech announces partnership for first liquid biopsy prostate cancer assay in India

US-based PanGIA Biotech, a pioneer in liquid biopsy technology, has announced its first international partnership, collaborating with Canary Oncoceutics India in Tamil Nadu.

1 mins

Cipla brings revolutionary diabetes management solution to India

Mumbai-based pharma firm Cipla has announced regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza (insulin human) Inhalation Powder in India. Developed and manufactured by Mann Kind Corporation (USA), Afrezza offers a groundbreaking treatment designed to improve glycemic control in adults with diabetes mellitus.

1 mins

Strand Life Sciences introduces blood-based test for early detection of multiple cancers

Bengaluru-based genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers.

1 mins

Dr. Reddy's launches Toripalimab for treatment of Nasopharyngeal Carcinoma in India

Hyderabad-based Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. Toripalimab is a New Biological Entity (NBE).

1 mins

Mestastop Solutions receives Rs 2.66 Cr worth grant from BIRAC

Mestastop Solutions, a Bengaluru-based biotech company focused on stopping the spread of cancer, has been awarded Rs 2.66 crore grant by the Biotechnology Industry Research Assistance Council (BIRAC) under the focused call of 'establishment of preclinical models for drug discovery'.

1 mins

Anabio Technologies acquires Microbe Investigations in Switzerland

Anabio, a Bengaluru-based femtech startup innovating in the menstrual hygiene space, has announced its acquisition of Microbe Investigations Switzerland (MIS), a Zurich-based company in microbial research and diagnostics.

1 mins

International Pathogen Surveillance Network announces first recipients of grants

The World Health Organization (WHO) and partners announced 10 projects that will receive almost $2 million in grants to improve capacities in pathogen genomic surveillance.

1 mins

WHO announces first prequalification of TB diagnostic test

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert MTB/RIF Ultra.

1 mins

Indian Pharma Hits R&D Salvo

Pharma companies are constantly on the quest to discover the next big game-changer drug or therapeutic by leveraging the latest, cutting-edge innovation.

2 mins

Telangana's Bid to Achieve Positive Investment Growth

Hyderabad continues to be a global center for generic drugs and vaccines despite the fact that Telangana's pharmaceutical industry has seen ups and downs throughout the years due to proactive industry policies, initiatives, and state government actions. With the pharmaceutical industry in India expected to grow to $120-130 billion by 2030, Telangana plays a pivotal role in advancing global healthcare solutions.

7 mins

"We are focusing on developing 10 'Pharma Villages' to decentralise pharma production, taking manufacturing closer to rural areas"

With the Revanth Reddy led Telangana government completing its first year in office, Jayesh Ranjan, Principal Secretary of the Department of IT and Industries, shares his optimism about Telangana's future as a vibrant industrial hub.

5 mins

"A 'no-strings-attached' funding model from industry may go a long way in strengthening India's innovation landscape"

The Infosys Prize 2024 in Life Sciences has been awarded to Siddhesh been awarded to Siddhesh Kamat, Associate Professor in the Department of Biology at the Indian Institute of Science Education and Research (IISER), Pune, for his discoveries concerning bioactive lipids and their receptors, and their metabolic and signalling pathways.

2 mins

"India needs vaccines that are 'Made for India"

With a legacy of over 75 years in pioneering advancements with their vaccines within the Indian pharmaceutical landscape, Mumbai-based Novo Medi Sciences (Novo Group) has been instrumental in introducing many first-of-itskind vaccines in India, playing a vital role in public health and setting standards in healthcare quality and accessibility.

5 mins

"The pharma packaging landscape is evolving rapidly, driven by advancements in technology and changing regulatory landscapes"

Recently elevated from CEO to Chairman and Managing Director (CMD) of Ecobliss India, AVPS Chakravarthi, has been at the forefront of developing eco-friendly packaging technologies, particularly for the pharma, biotechnology and allied industries, worldwide.

4 mins

India's Transformative Leap in Medtech

India's medtech and diagnostics sector is poised for a transformative journey in 2025.

5 mins

Key Skills & Salary Trends in Healthcare & Pharma for 2025

India’s healthcare and pharmaceutical sectors have witnessed tremendous growth in the last decade, with cutting-edge technology being widely integrated into operations.

5 mins

DigiNerve unveils orthopaedics MS Course to connect medical education with surgical precision

DigiNerve, an EdTech platform by Jaypee Brothers Medical Publishers, is revolutionising orthopaedic medical education with the strategic launch of its comprehensive Orthopaedics MS course.

1 mins

Innovation serves as the backbone for Agilent: Celebrating 25 years in India

2024 marks Agilent's 25th anniversary in India. To celebrate this momentous occasion, Agilent announced the launch of two new products for the Indian market- Infinity III LC Series and New ProteoAnalyzer System, at the 17th edition of CPHI & PMEC India, organised by Informa Markets, from 26 to 28 November at the India Expo Centre, Greater Noida, Delhi-NCR.

5 mins

Heartnet appoints Indranil Das as Senior Advisor Technology

Bengaluru-based Heartnet India, an IoTbased solution dedicated to enhancing cardiac healthcare delivery, has announced the appointment of Indranil Das as Senior Advisor - Technology. In this role, Das will play a pivotal role in guiding the company's technological advancements and strategic initiatives.

1 mins

Amgen India ropes in Naveen Gullapalli as MD

Amgen has announced the appointment of Naveen Gullapalli as Managing Director of Amgen India.

1 mins

Infinx names Ninad Chavda as new Chief Financial Officer

Infinx, a trusted provider of artificial intelligence (AI)powered solutions for patient access and revenue cycle management, has announced the appointment of Ninad Chavda as Chief Financial Officer (CFO).

1 mins

Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser

Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.

1 mins

Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare

RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).

1 mins

NATHEALTH Foundation inducts Dr Indu Bhushan & Neeraj Jain to the board

NATHEALTH Foundation has announced the induction of two distinguished leaders, Dr Indu Bhushan and Neeraj Jain, to its Board.

1 mins

RSSDI study lays focus on Yoga and Diabetes Prevention

Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.

1 mins

Gene mutation likely cause for developing autism in early childhood: RGCB study

Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.

1 mins

IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing

A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.

1 mins

New technology for unambiguous detection of HIV genome using tailored fluorogenic tests

A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.

1 mins

Parse Biosciences announces expansion of Evercode BCR product line

Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.

1 mins

Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data

Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.

1 mins

Sartorius Stedim Biotech opens new centre for bioprocess innovation in US

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.

1 mins

Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research

Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.

1 mins

すべてのストーリーを読む Bio Spectrum

Bio Spectrum Description:

出版社: MM-Activ-Sci-Tech-Communication

カテゴリ: Business

言語: English

頻度: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.